Glaucoma is one of the leading causes of blindness worldwide, and vision loss, due to the loss of retinal ganglion cells (RGCs), cannot currently be reversed with any treatment. Some studies have ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The top Healio glaucoma-related items this year covered ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Therapies for treating glaucoma, including doxycycline ...

AI (artificial intelligence) that is trained to recognize red flags in retinal images and clinical information can predict if and when people at high risk of glaucoma, usually referred to as "glaucoma ...

Conventional SLT requires gonioscopy-lens visualization; DSLT fires 120 pulses (1.8 mJ, 50 Hz) transsclerally with eye tracking, completing most sessions without contact. At 2 months, mean IOP fell ...

The US Food and Drug Administration (FDA) has approved an intracameral implant with 75 mcg of travoprost to reduce intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular ...

Glaucoma can occur in children, although it is rare. Early diagnosis and treatment are essential to prevent permanent vision loss. Glaucoma is an eye condition that damages the optic nerve. Without ...

Glaucoma is not fatal. Without treatment, glaucoma can cause significant vision loss and eventually blindness, but early treatment can help protect vision and slow the progression of the disease.

Scientists have developed a novel approach that allows stem cells to be turned into retinal ganglion cells that are capable of migrating and surviving in the eye's retina. This approach presents a ...